UPS to acquire Smartways Logistics to expand healthcare business in Asia Pacific
The acquisition will strengthen UPS Healthcare's transportation network in Australia and New Zealand, with the deal expected to close in the first half of 2027.
United Parcel Service announced Tuesday that it has entered into an agreement to acquire Smartways Logistics, a healthcare logistics provider operating in Australia and New Zealand, as the company expands its specialized transportation services across Asia Pacific.
The acquisition will strengthen UPS Healthcare’s ability to handle time sensitive shipments, including medical devices, clinical trial materials, pharmaceuticals, and radiopharmaceuticals.
Smartways operates a network of more than 350 drivers, providing same day ground delivery, overnight transportation, next flight out services, and reverse logistics for healthcare customers.
The transaction is expected to close in the first half of 2027, subject to customary regulatory approvals. UPS did not disclose the purchase price or other financial terms.
“As healthcare becomes increasingly complex, logistics plays an even more critical role,” said Wilfredo Ramos, UPS executive vice president and chief international, healthcare and supply chain solutions officer.
The acquisition follows UPS’s broader expansion of its healthcare logistics network, including the recent opening of its Clark hub in the Philippines and investments in temperature controlled transportation infrastructure.
The news moving money, markets, and the world—before your day starts.
Daily. Free. Join 34,000+ readers across crypto, finance, and policy.
UPS Healthcare generated $3 billion in quarterly revenue for the third consecutive quarter in the third quarter of 2026, reflecting the company’s continued focus on specialized healthcare logistics.
Smartways Chairman Marcus Wyborn said the acquisition would combine the company’s regional expertise with UPS’s global distribution network, allowing it to expand services for healthcare customers.
UPS operates more than 21 million square feet of healthcare distribution space globally, supporting pharmaceutical, medical device, laboratory, and clinical trial supply chains.
Disclosure: This article was edited by Vivian Nguyen. For more information on how we create and review content, see our Editorial Policy.

